Dianthus Therapeutics (DNTH) Net Income towards Common Stockholders (2017 - 2025)
Dianthus Therapeutics (DNTH) reported Net Income towards Common Stockholders of -$36.77 million for Q3 2025, compared with -$25.17 million a year earlier.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Net Income towards Common Stockholders (2017 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Dianthus Therapeutics' Net Income towards Common Stockholders came in at -$126.38 million; for FY2024, it was -$85 million.
- By year, Net Income towards Common Stockholders came in at -$43.6 million in FY2023, -$28.5 million in FY2022, -$71.14 million in FY2021 and -$74.94 million in FY2020.
- The Q3 2025 figure ranks as the lowest quarterly Net Income towards Common Stockholders in data going back to Q2 2017.
- Per Business Quant data, the three quarters before Q3 2025 came in at -$31.63 million (Q2 2025), -$29.51 million (Q1 2025) and -$28.47 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Dianthus Therapeutics | 3.78 Bn | 3.73 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -36.77 Mn |
| Jun 30, 2025 | -31.63 Mn |
| Mar 31, 2025 | -29.51 Mn |
| Dec 31, 2024 | -28.47 Mn |
| Sep 30, 2024 | -25.17 Mn |
| Jun 30, 2024 | -17.61 Mn |
| Mar 31, 2024 | -13.75 Mn |
| Dec 31, 2023 | -10.60 Mn |
| Sep 30, 2023 | -14.76 Mn |
| Jun 30, 2023 | -11.14 Mn |
| Mar 31, 2023 | -7.09 Mn |
| Dec 31, 2022 | -10.10 Mn |
| Sep 30, 2022 | -7.78 Mn |
| Jun 30, 2022 | -5.70 Mn |
| Mar 31, 2022 | -4.88 Mn |
| Dec 31, 2021 | -19.29 Mn |
| Sep 30, 2021 | -17.43 Mn |
| Jun 30, 2021 | -16.93 Mn |
| Mar 31, 2021 | -17.49 Mn |
| Dec 31, 2020 | -18.17 Mn |
API Access
Dianthus Therapeutics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();